DJIA 17,018.76 -20.73 -0.12%
NASDAQ 4,541.00 8.90 0.20%
S&P 500 1,989.96 -2.41 -0.12%
market minute promo

5.37 0.25 (4.88%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PGNX $5.37 4.88%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.14
Previous Close $5.12
Daily Range $5.01 - $5.36
52-Week Range $3.10 - $7.45
Market Cap $373.5M
P/E Ratio -8.39
Dividend (Yield) $0.00 (0.0%)
Volume 690,377
Average Daily Volume 1,293,549
Current FY EPS -$0.02





Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website:

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

2nd Half Of 2014 Biotechnology Catalysts--Part 4

Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog

US Stock Futures Signal Higher Start On Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q2 2014 Results - Earnings Call Transcript

Progenics Pharmaceuticals (PGNX) Q2 2014 Results - Earnings Call Webcast

Earnings Scheduled For August 8, 2014

Will Progenics (PGNX) Disappoint this Earnings Season? - Analyst Blog

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

An Inefficient Stock Market Will Catch Up To Progenics

See More PGNX News...

PGNX's Top Competitors

PGNX $5.37 (4.88%)
Current stock: PGNX
AMGN $133.20 (0.51%)
Current stock: AMGN
GILD $104.19 (1.88%)
Current stock: GILD
BIIB $340.96 (0.68%)
Current stock: BIIB